- Home
- SIEB vs XBIT Comparison
SIEB vs XBIT Comparison
Compare SIEB & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIEB
- XBIT
- Stock Information
- Founded
- SIEB 1886
- XBIT 2005
- Country
- SIEB United States
- XBIT United States
- Employees
- SIEB N/A
- XBIT N/A
- Industry
- SIEB Investment Bankers/Brokers/Service
- XBIT Pharmaceuticals and Biotechnology
- Sector
- SIEB Finance
- XBIT Health Care
- Exchange
- SIEB Nasdaq
- XBIT Nasdaq
- Market Cap
- SIEB 95.1M
- XBIT 105.2M
- IPO Year
- SIEB N/A
- XBIT 2015
- Fundamental
- Price
- SIEB $3.35
- XBIT $2.94
- Analyst Decision
- SIEB
- XBIT
- Analyst Count
- SIEB 0
- XBIT 0
- Target Price
- SIEB N/A
- XBIT N/A
- AVG Volume (30 Days)
- SIEB 36.6K
- XBIT 55.6K
- Earning Date
- SIEB 05-09-2025
- XBIT 05-09-2025
- Dividend Yield
- SIEB N/A
- XBIT N/A
- EPS Growth
- SIEB 57.14
- XBIT N/A
- EPS
- SIEB 0.33
- XBIT N/A
- Revenue
- SIEB $83,639,000.00
- XBIT N/A
- Revenue This Year
- SIEB N/A
- XBIT N/A
- Revenue Next Year
- SIEB N/A
- XBIT N/A
- P/E Ratio
- SIEB $10.15
- XBIT N/A
- Revenue Growth
- SIEB 17.39
- XBIT N/A
- 52 Week Low
- SIEB $1.41
- XBIT $2.65
- 52 Week High
- SIEB $3.34
- XBIT $9.45
- Technical
- Relative Strength Index (RSI)
- SIEB 70.68
- XBIT 44.32
- Support Level
- SIEB $2.91
- XBIT $2.77
- Resistance Level
- SIEB $3.04
- XBIT $3.38
- Average True Range (ATR)
- SIEB 0.24
- XBIT 0.33
- MACD
- SIEB 0.05
- XBIT -0.01
- Stochastic Oscillator
- SIEB 96.87
- XBIT 29.90
About SIEB Siebert Financial Corp.
Siebert Financial Corp is a holding company. It conducts retail discount brokerage business through its wholly-owned subsidiary. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.